Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo.

Cristiana Savorè; Chu Zhang; Caroline Muir; Riting Liu; Jeffrey Wyrwa; Jun Shu; Haiyen E Zhau; Leland W K Chung; Daniel D Carson; Mary C Farach-Carson

doi:10.1007/s10585-005-2339-3

Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo.

Identifier:nobleid.org/w1/20260515/2AB33F4D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2AB33F4D.svg?ark=w1%2F20260515%2F2AB33F4D)](https://nobleid.org/work/w1/20260515/2AB33F4D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo.

Identifier:nobleid.org/w1/20260515/2AB33F4D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2AB33F4D.svg?ark=w1%2F20260515%2F2AB33F4D)](https://nobleid.org/work/w1/20260515/2AB33F4D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work